CXCR4, expressed on the surface of hematopoietic stem cells and leukemia blast cells, is activated by CXCL12, and it participates in leukemia cell proliferation and infiltration, as well as in conferring resistance to chemotherapy drugs (11–13). Here, CXCR4 is linked to leukemia.